Data / Form D filings / Everist Genomics, Inc.
Everist Genomics, Inc.: Form D filings
Everist Genomics, Inc., a biotechnology company in Ann Arbor, MI, filed 2 Form D notices with the SEC in 2012. The latest, on September 4, 2012, reports $3.1 million sold of a $30 million offering to 11 investors.
Find out what Everist Genomics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 709 WEST ELLSWORTH ROAD, 2ND FLOOR, Ann Arbor, MI, 48108
- Phone
- (734) 929-9475
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1542521
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 4, 2012 | New notice | $30,000,000 | $3,061,999 | $26,938,001 | 11 | Aug 21, 2012 | sec.gov |
| Feb 16, 2012 | New notice | $9,730,693 | $9,479,766 | $250,927 | 25 | Feb 3, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Randal Charlton | Director | |
| Alex Charlton | Executive Officer, Director | |
| Steve Everist | Director | |
| Tom Everist | Executive Officer, Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Sep 3, 2012 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Everist Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.